Results 41 to 50 of about 1,750,321 (260)

Expulsion of intrauterine devices after postpartum placement by timing of placement, delivery type, and intrauterine device type: a systematic review and meta-analysis [PDF]

, 2020
ObjectivesTo provide updated and more detailed pooled intrauterine device expulsion rates and expulsion risk estimates among women with postpartum intrauterine device placement by timing of insertion, delivery type, and intrauterine device type to inform
Averbach, Sarah H, Jamieson, Denise J, Ermias, Yokabed, Marchbanks, Polly A, Jatlaoui, Tara C, Curtis, Kathryn M, Whiteman, Maura K, Berry-Bibee, Erin, Tepper, Naomi K, Jeng, Gary   +9 more
core   +1 more source

Intrauterine device checks [PDF]

Journal of Family Planning and Reproductive Health Care, 2012
Thank you for publishing the article by Draper et al. on intrauterine device (IUD) checks.1 I would like to highlight an omission that is potentially confusing. The authors state “until …
openaire   +2 more sources

Non-contraceptive applications of the levonorgestrel intrauterine system [PDF]

, 2010
Maria Isabel Rodriguez, Philip D DarneyDepartment of Obstetrics, Gynecology, and Reproductive Sciences, San Francisco General Hospital and Bixby Center for Global Reproductive Health, University of California, San Francisco, CA, USAAbstract: Intrauterine
Maria Isabel Rodriguez, Darney, Philip D, Philip D Darney, Philip Darney, Rodriguez, Maria Isabel, null Rodriguez   +5 more
core   +1 more source

Die Bedeutung der Aktinomykose in der Gynäkologie und Geburtshilfe [PDF]

, 2005
Das erste Auftreten von Aktinomykose beim Menschen wurde 1878 durch den Berliner Chirurgen James Israel berichtet. 1881 wurde der erste Fall einer Genitalaktinomykose bekannt.
Parr, Julia Katharina
core   +1 more source

Rapid Fabrication of Self‐Propelled and Steerable Magnetic Microcatheters for Precision Medicine

Advanced Materials, EarlyView.
A rapid Joule heating fabrication method for the production of self‐propelling, adaptive microcatheters, with tunable stiffness and integrated microfluidic channels is presented. Demonstrated through three microrobotic designs, including a steerable guiding catheter, an untethered wave‐crawling TubeBot, and a distal‐end propelled microcatheter, it was ...
Zhi Chen, Boris Rivkin, David Castellanos‐Robles, Ivan Soldatov, Lukas Beyer, Mariana Medina‐Sánchez   +5 more
wiley   +1 more source

Comparison between Cupper T380 IUD and Multiload 375 IUD in early post partum insertion

Middle East Fertility Society Journal, 2011
Objectives: Comparison between Cupper T380 IUD (intrauterine device) and Multiload 375 IUD insertion in early postpartum period in regard to safety, efficacy, side effects, and complications.
N.S. El Beltagy, E.A. Darwish, M.S. Kasem, N.M. Hefila   +3 more
doaj   +1 more source

An Injectable ROS‐Responsive Nanozyme Hydrogel Regulates the Uterine Microenvironment to Prevent Intrauterine Adhesions

Advanced Science, EarlyView.
The injectable CeTA@GPP hydrogel is administered via intrauterine injection, forming a protective barrier. In the high ROS inflammatory microenvironment of injured endometrium, boronate ester cleavage triggers responsive CeTA release and local enrichment.
Peixian Cheng, Jian Song, Yuxin Li, Ming Chen, Zeshen Liang, Binyao Qiu, Xuemin Liu, Xuetao Shi, Yong Fan   +8 more
wiley   +1 more source

A comparison of the expected and actual pain experienced by women during insertion of an intrauterine contraceptive device. [PDF]

, 2015
Objective: To compare the expected and actual pain experienced with the insertion of intrauterine contraception in women, and to determine whether either of these are related to their personal circumstances, or affected their satisfaction with the ...
Brima, N, Akintomide, H, Iguyovwe, V, Mann, S   +3 more
core  

Intrauterine Contraception [PDF]

, 2016
Currently, there are only two basic types of intrauterine devices (IUDs): copper and hormonal. However, other types of IUDs are under development, some of which are in clinical trials around the world.
Hsia, Jennifer K, Creinin, Mitchell D
core   +1 more source

Therapy for Myhre Syndrome: Goals, Misconceptions, and Current Agents

American Journal of Medical Genetics Part C: Seminars in Medical Genetics, EarlyView.
ABSTRACT Myhre Syndrome (MYHRS, MIM #139210) is a rare, multisystem connective tissue disorder caused by recurrent heterozygous gain‐of‐function pathogenic variants in the SMAD4 gene, a key player in TGF‐β signaling and a regulator of extracellular matrix homeostasis.
Alessandro De Falco, Alfonso Manuel D'Alessio, Nicola Brunetti‐Pierri   +2 more
wiley   +1 more source